Advancements in Capecitabine-Loaded Nanocomposites as a Cutting-Edge Cancer Therapy- A Review

被引：0
作者：
Mehrab Pourmadadi
Mahdi Maleki
Amin Shamsabadipoura
Abbas Rahdar
Suresh Ghotekar
机构：
[1] University of Tehran,Department of Biotechnology, School of Chemical Engineering, College of Engineering
[2] University of Zabol,Department of Physics, Faculty of Sciences
[3] Chettinad Academy of Research and Education,Centre for Herbal Pharmacology and Environmental Sustainability, Chettinad Hospital and Research Institute
来源：
BioNanoScience | 2024年 / 14卷
关键词：
Capecitabine; Drug delivery systems; Cancer therapy; Nanoparticles; Co-delivery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
These days, cancers are one of the major reasons of death among humans worldwide. Thus, scientists and researchers are trying to employ applicable techniques to treat cancers more efficiently with lower side effects. On this occasion, various nanoparticles as potential nanocarriers have been used to load anti-cancer drugs to ameliorate the drug delivery restrictions in chemotherapeutic procedures. In the current study, capecitabine (CAP) as a prodrug has been introduced, and the application of diverse capecitabine-loaded nanoparticles for treating cancers such as breast or colorectal cancer has been reviewed. Besides, the co-delivery capability of CAP with other drugs in a stimuli-responsive manner has made these drug-loaded nanoparticles a potential candidate for drug delivery purposes, especially for treating cancers more efficiently.
引用
收藏
页码：337 / 345
页数：8
相关论文
共 75 条
  • [41] Zheng L(2023)Carbon nanostructures as therapeutic cargoes: recent developments and challenges C 9 3-undefined
  • [42] Wang R(2021)Colon targeted dosage form of capecitabine using folic acid anchored modified carbon nanotube: In vitro cytotoxicity, apoptosis and in vivo roentgenographic study Drug Development and Industrial Pharmacy 47 1401-undefined
  • [43] Valencia-Lazcano AA(2018)Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: Preparation, cytotoxic, pharmacokinetic, and pathological evaluation Drug Development and Industrial Pharmacy 44 1572-undefined
  • [44] Liu L(2020)HER2 targeted biological macromolecule modified liposomes for improved efficacy of capecitabine in breast cancer International Journal of Biological Macromolecules 150 631-undefined
  • [45] Brown EN(2012)Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells Journal of gastrointestinal and liver diseases : JGLD 21 187-undefined
  • [46] Abu-Shahin FI(2019)Silver nanoparticle/capecitabine for breast cancer cell treatment Toxicology in Vitro 61 104600-undefined
  • [47] Warfield BM(2014)Folate-decorated PEG–PLGA nanoparticles with silica shells for capecitabine controlled and targeted delivery International Journal of Pharmaceutics 464 225-undefined
  • [48] Reigan P(undefined)undefined undefined undefined undefined-undefined
  • [49] Derakhshani A(undefined)undefined undefined undefined undefined-undefined
  • [50] Nazari-Vanani R(undefined)undefined undefined undefined undefined-undefined
12345678